Literature DB >> 17900265

Acquired cold urticaria symptoms can be safely prevented by ebastine.

M Magerl1, J Schmolke, F Siebenhaar, T Zuberbier, M Metz, M Maurer.   

Abstract

BACKGROUND: Acquired cold urticaria (ACU) is a skin condition, in which exposure to cold results in wheals and itching and sometimes general systemic complications. It has a profound impact on patient quality of life. Second-generation antihistamines are recommended as the first-line treatment, but to date only a few have been scientifically tested for this condition. AIM: To assess the safety and efficacy of ebastine in preventing ACU symptoms.
METHODS: Twenty-two adult ACU patients participated in a double-blind crossover trial of 20 mg ebastine. The safety of ebastine was sensitively assessed with a psychometric battery testing cognitive performance and mood. After cold challenge, wheal and erythema were assessed by the investigator and the intensities of pruritus and burning were rated by the subject.
RESULTS: Ebastine had no negative impact on any of the parameters of cognitive performance or mood. It dramatically reduced the number of patients who experienced wheals, pruritus, and burning after challenge.
CONCLUSION: Ebastine is safe and effective in preventing the symptoms of ACU.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900265     DOI: 10.1111/j.1398-9995.2007.01500.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

1.  [Sociomedical implications of the inability to commute in patients with cold urticaria].

Authors:  W Nürnberg; J Grabbe; H-J Glawe; R Stoll
Journal:  Hautarzt       Date:  2010-03       Impact factor: 0.751

2.  Modern approaches to the diagnosis and treatment of cold contact urticaria.

Authors:  Karoline Krause; Torsten Zuberbier; Marcus Maurer
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

Review 3.  Physical urticaria.

Authors:  Marina Abajian; Agnieszka Młynek; Marcus Maurer
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

4.  [Cold-induced urticaria and angioedema. Classification, diagnosis and therapy].

Authors:  K Krause; F Degener; S Altrichter; E Ardelean; D Kalogeromitros; M Magerl; M Metz; F Siebenhaar; K Weller; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

Review 5.  [Urticaria … and treatment fails].

Authors:  B Wedi; D Wieczorek; U Raap; A Kapp
Journal:  Hautarzt       Date:  2013-09       Impact factor: 0.751

6.  Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines.

Authors:  S Rico; Rm Antonijoan; Mj Barbanoj
Journal:  J Asthma Allergy       Date:  2009-08-31

Review 7.  Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal.

Authors:  Adam Fabisiak; Jakub Włodarczyk; Natalia Fabisiak; Martin Storr; Jakub Fichna
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

8.  Review of cold-induced urticaria characteristics, diagnosis and management in a Western Canadian allergy practice.

Authors:  Peter Stepaniuk; Kateryna Vostretsova; Amin Kanani
Journal:  Allergy Asthma Clin Immunol       Date:  2018-12-18       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.